Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Samsara Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Samsara Therapeutics

Samsara Therapeutics

Samsara Therapeutics: Pioneering biopharmaceutical solutions for rare genetic and neurodegenerative diseases.

HQ
Lewes, DE, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Samsara Therapeutics is a biopharmaceutical company dedicated to discovering first-in-class therapeutics for rare genetic and neurodegenerative diseases. Their mission focuses on treating neurodegeneration by enhancing autophagy, a cellular process that removes damaged components. By leveraging their extensive platform for identification, chemical optimization, and in vivo testing, Samsara aims to extend healthy lifespans and improve the quality of life for patients and their families.

Samsara Therapeutics has made significant strides in developing a robust pipeline for therapeutic discovery. Their innovative approach to autophagy activation has positioned them as a leader in the field of age-related neurodegenerative disease treatment. The company continues to push the boundaries of biopharmaceutical research, contributing valuable insights and potential treatments that could transform patient care and outcomes.

Samsara Therapeutics - Similar Companies

Casma Therapeutics logo

Casma Therapeutics

casmatx.com

PAQ Therapeutics logo

PAQ Therapeutics

paqtx.com

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Star Therapeutics logo

Star Therapeutics

Denali Therapeutics logo

Denali Therapeutics

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

Arkuda Therapeutics logo

Arkuda Therapeutics

arkudatx.com

Fountain Therapeutics logo

Fountain Therapeutics

fountaintx.com

Libra Therapeutics logo

Libra Therapeutics

Aztherapies logo

Aztherapies

Inflammasome Therapeutics logo

Inflammasome Therapeutics

inflam.com

Orphan Star Therapeutics logo

Orphan Star Therapeutics

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Chaperone Therapeutics logo

Chaperone Therapeutics

Selva Therapeutics logo

Selva Therapeutics

Samsara Therapeutics - Quick Facts

Who are Samsara Therapeutics' competitors?

Companies similar to Samsara Therapeutics include Casma Therapeutics, PAQ Therapeutics, CuraSen Therapeutics and Star Therapeutics.

When was Samsara Therapeutics founded?

Samsara Therapeutics was founded in 2018.

Where is Samsara Therapeutics' headquarters located?

Samsara Therapeutics' headquarters is located in Lewes, DE, US.

How much has Samsara Therapeutics raised to-date?

As of Sep 6, 2022, Samsara Therapeutics has raised a total of $13.5M (USD).

How many employees does Samsara Therapeutics have?

Samsara Therapeutics has 36 employees as of Feb 5, 2024.

Samsara Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified